Title

Botulinum Toxin Consensus Statement - Foreword

Document Type

Other contribution to a refereed journal

Publication Date

2010

Abstract

People with neurological disorders seek effective treatments for the management of their movement disorder, the reduction in pain and discomfort and for increasing their participation in everyday life. We set out to investigate the role of Botulinum neurotoxin A (BoNT-A) in achieving these goals. We were guided by Albert Szent-Györgyi’s premise that ‘Discovery consists of seeing what everybody has seen and thinking what nobody has thought’. The Cerebral Palsy Institute identified the need to develop an International Consensus Statements for BoNT-A in the treatment of neurological conditions based on a literature review and audit of practice variations in Australia.

Comments

Due to copyright restrictions the publisher's version/PDF of this article is unavailable for download.

Staff and Students of the University of Notre Dame Australia may access the full text of this article here

This article may be accessed from the publisher here

The European Journal of Neurology may be accessed from the National Library of Australia here


Link to Full Text

Share

COinS